Edwards Lifesciences Sees Q2 Adj. EPS $0.54-$0.60 vs $0.52 Est., Sales $1.25B-$1.33B vs $1.25B Est.; Raises FY21 Adj. EPS $2.00-$2.20 To $2.07-$2.27 vs $2.13 Est., Sees Sales $4.9B-$5.3B vs $5.08B Est.